New cobalt complex with dihydroxycoumarin: synthesis and kinetics of its redox-activated dissociation

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

A new redox-active cobalt(III) complex containing the 2-oxo-2Н-chromene-6,7-diolate dianion and 4,4ʹ-dimethoxy-2,2ʹ-bipyridine as ligands is synthesized. The reduction of the sythesized complex with ascorbic acid in an inert atmosphere is studied in situ by NMR spectrocopy. The reduction is shown to result in the release of 6,7-dihydrocycoumarin acting as a model drug. This process has the first order with respect to the initial complex.

Толық мәтін

Рұқсат жабық

Авторлар туралы

К. Spiridonov

Moscow State University; Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences

Email: khakina90@ineos.ac.ru
Ресей, Moscow; Moscow

I. Nikovskii

Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences

Email: khakina90@ineos.ac.ru
Ресей, Moscow

Е. Antoshkina

Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences; Moscow Institute of Physics and Technology (National Research University)

Email: khakina90@ineos.ac.ru
Ресей, Moscow; Moscow oblast, Dolgoprudnyi

E. Khakina

Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences

Хат алмасуға жауапты Автор.
Email: khakina90@ineos.ac.ru
Ресей, Moscow

Yu. Nelyubina

Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences

Email: khakina90@ineos.ac.ru
Ресей, Moscow

Әдебиет тізімі

  1. Brown J.M., Giaccia A.J. // Cancer Res. 1998. V. 58. P. 1408.
  2. Xiong Q., Liu B., Ding M. et al. // Cancer Lett. 2020. V. 486. P. 1.
  3. Vaupel P., Thews O., Hoeckel M. // Med. Oncology. 2001. V. 18. P. 243.
  4. Ruirui L., Feifei P., Jia C. et al. // Asian J. Pharmaceutic. Sci. 2020. V. 15. P. 311.
  5. Renfrew A.K. // Metallomics. 2014. V. 6. P. 1324.
  6. Hall M.D., Failes T.W., Yamamoto N. et al. // Dalton Trans. 2007. P. 3983.
  7. Palmeira-Mello M.V., Caballero A.B., Ribeiro J.M. et al. // J. Inorg. Biochem. 2020. V. 211. P. 111211.
  8. Tsitovich P.B., Spernyak J.A., Morrow J.R. // Angew. Chem. Int. Ed. 2013. V. 52. P. 13997.
  9. Renfrew A.K., O′Neill E.S., Hambley T.W. et al. // Coord. Chem. Rev. 2018. V. 375. P. 221.
  10. McPherson J.N., Hogue R.W., Akogun F.S. et al. // Inorg. Chem. 2019. V. 58. P. 2218.
  11. Khakina E.A., Nikovskii I.A., Babakina D.A. et al. // Russ. J. Coord. Chem. 2023. V. 49. P. 24. https://doi.org/10.1134/S1070328422700105
  12. Vlcek A.A. // Inorg. Chem. 1967. V. 6. P. 1425.
  13. Ma D.-L., Wu C., Cheng S.-S. et al. // Int. J. Mol. Sci. 2019. V. 20. P. 341.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
2. Scheme 1.

Жүктеу (85KB)
3. Scheme 2.

Жүктеу (158KB)
4. Fig. 1. Electrospray ionization mass spectrum of complex I recorded for positive ions.

Жүктеу (89KB)
5. Fig. 2. NMR spectrum of 1H of complex I in DMSO-d6 solution at room temperature.

Жүктеу (134KB)
6. Fig. 3. NMR spectrum 13C of complex I in DMSO-d6 solution at room temperature.

Жүктеу (119KB)
7. Fig. 4. Dynamics of changes in the NMR spectrum 1H over time during the reduction of complex I with ascorbic acid in an argon atmosphere (the spectrum was recorded in a mixture of acetonitrile-d3 and deuterated water, 3.7 : 1 vol.).

Жүктеу (112KB)
8. Fig. 5. Mass spectrum of the products of reduction of complex I with ascorbic acid, recorded for positive ions.

Жүктеу (119KB)
9. Fig. 6. Kinetic curve of consumption of complex I during reduction with ascorbic acid in an argon atmosphere (a) and dependence of the logarithm of the concentration lnc of complex I on the reaction time (b).

Жүктеу (85KB)

© Российская академия наук, 2024